Christie et al. posited that upregulation of ABCB1 through transcriptional fusion—leading to increased multidrug resistance protein (MDR1) in tumor cells—should be associated with the number of previous MDR1-substrate CT lines. This evidence concerns the gene ABCB1 and neoplasm.